Policy on Open Access/Article Charges

Open Access

Papers in Kidney Cancer are currently published open access with associated fees waived until the end of 2022. This means that every article, when first posted as a pre-press article to when it is included as part of an issue, is immediately, permanently, and openly available online for readers to view, download, share, and reuse.

Beginning January 1, 2023, the journal will move from its current hybrid publication model to a true gold open access journal. Therefore, authors of accepted papers submitted after that date will be required to pay an open access fee of US$500 / EUR500 to publish under the CC BY-NC 4.0 license on acceptance for publication. Authors who envisage difficulties paying the article processing charge may appeal to the Editors-in-chief to discuss waiving the charge. Waivers are also available for corresponding authors from eligible countries as identified by Research4Life project. A fee waiver may also be available if your institution has a transformative agreement with IOS Press.

PubMedCentral deposits

This journal deposits open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library but can only do so if the article received NIH funding or if any of the authors are NIH, or associated partners, employees. Please refer to the PMC Funder Deposit List at the NIH Public Access Policy for details.